Suzanne Egyházi

2.4k total citations · 1 hit paper
27 papers, 1.8k citations indexed

About

Suzanne Egyházi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Suzanne Egyházi has authored 27 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Suzanne Egyházi's work include Melanoma and MAPK Pathways (8 papers), Cutaneous Melanoma Detection and Management (8 papers) and Epigenetics and DNA Methylation (7 papers). Suzanne Egyházi is often cited by papers focused on Melanoma and MAPK Pathways (8 papers), Cutaneous Melanoma Detection and Management (8 papers) and Epigenetics and DNA Methylation (7 papers). Suzanne Egyházi collaborates with scholars based in Sweden, United States and Austria. Suzanne Egyházi's co-authors include Johan Hansson, Ulrik Ringborg, Anton Platz, Jonas Bergh, Lance D. Miller, Per Hall, Peter Shaw, Alexander Ploner, Lukas C. Amler and Edison T. Liu and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Suzanne Egyházi

26 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

2005 613 citations Yudi Pawitan, Judith Bjöhle et al. Breast Cancer Research profile →

Peers

Countries citing papers authored by Suzanne Egyházi

Since Specialization

Citations

This map shows the geographic impact of Suzanne Egyházi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Egyházi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Egyházi more than expected).

Fields of papers citing papers by Suzanne Egyházi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Egyházi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Egyházi. The network helps show where Suzanne Egyházi may publish in the future.

Co-authorship network of co-authors of Suzanne Egyházi

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Egyházi. A scholar is included among the top collaborators of Suzanne Egyházi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Egyházi. Suzanne Egyházi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HSP60 Predicts Survival in Advanced Serous Ovarian Cancer 2013 ·International Journal of Gynecological Cancer ·Elisabet Hjerpe, Suzanne Egyházi, Joseph W. Carlson, (unknown), Kjell Schedvins, Hemming Johansson, Maria C. Shoshan, Elisabeth Åvall‐Lundqvist	43
2	P2.17 Proteomics and Gene Expression Profiling of Melanoma Chemotherapy Response in Tumors 2012 ·Annals of Oncology ·Carolina Johansson, Alireza Azimi, Maria Pernemalm, Yudi Pawitan, Marianne Frostvik Stolt, Vladimir Lazar, Joakim Lundeberg, Janne Lehtiö, Suzanne Egyházi, Johan Hansson	3
3	High Frequency of p16 Promoter Methylation in NRAS-Mutated Cutaneous Melanoma 2010 ·Journal of Investigative Dermatology ·Anders Jönsson, Rainer Tuominen, (unknown), Johan Hansson, Suzanne Egyházi	46
4	MicroRNA Expression Profiles Associated with Mutational Status and Survival in Malignant Melanoma 2010 ·Journal of Investigative Dermatology ·Stefano Caramuta, Suzanne Egyházi, Monica Rodolfo, Daniela Witten, Johan Hansson, Catharina Larsson, Weng‐Onn Lui	182
5	Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E–mutated melanomas 2008 ·Molecular Cancer Therapeutics ·Keiran S.M. Smalley, Mercedes Lioni, Maurizia Dalla Palma, Min Xiao, Brijal Desai, Suzanne Egyházi, Johan Hansson, (unknown), Alastair J. King, Patricia Van Belle, David E. Elder, Keith T. Flaherty, Meenhard Herlyn, Katherine L. Nathanson	244
6	Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma 2008 ·Cancer Immunology Immunotherapy ·C. Christian Johansson, Suzanne Egyházi, Giuseppe Masucci, Helena Harlin, Dimitrios Mougiakakos, Isabel Poschke, Bo Nilsson, (unknown), Rainer Tuominen, (unknown), Marianne Frostvik Stolt, Johan Hansson, Rolf Kiessling	41
7	Lack of Cytoplasmic ERK Activation Is an Independent Adverse Prognostic Factor in Primary Cutaneous Melanoma 2008 ·Journal of Investigative Dermatology ·(unknown), (unknown), (unknown), Bo Nilsson, Suzanne Egyházi, Johan Hansson	30
8	MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters 2008 ·Pigment Cell & Melanoma Research ·Veronica Höiom, Rainer Tuominen, Max Käller, (unknown), Afshin Ahmadian, Eva Månsson‐Brahme, Suzanne Egyházi, Klas Sjöberg, Joakim Lundeberg, Johan Hansson	32
9	Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site 2007 ·Molecular Oncology ·Anton Platz, Suzanne Egyházi, Ulrik Ringborg, Johan Hansson	201
10	Amplification of the cyclin D1 locus 11q13 in melanoma metastases: association to cyclin D1 protein expression 2006 ·Melanoma Research ·Rainer Tuominen, (unknown), Suzanne Egyházi	0
11	Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts breakdown → 2005 ·Breast Cancer Research ·Yudi Pawitan, Judith Bjöhle, Lukas C. Amler, (unknown), Suzanne Egyházi, Per Hall, Xia Han, Lars Holmberg, Fei Huang, Sigrid Klaar, Edison T. Liu, Lance D. Miller, Hans Nordgren, Alexander Ploner, Kerstin Sandelin, Peter Shaw, Johanna Smeds, Lambert Skoog, Sara Wedrén, Jonas Bergh	613
12	O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma 2003 ·British Journal of Cancer ·S. Ma, Suzanne Egyházi, Takayuki Ueno, C. Lindholm, Emiko L. Kreklau, Ulrika Stierner, Ulrik Ringborg, Johan Hansson	60
13	Analysis of O6-methylguanine-DNA methyltransferase in melanoma tumours in patients treated with dacarbazine-based chemotherapy 2002 ·Melanoma Research ·Shanshan Ma, Suzanne Egyházi, (unknown), Ulrik Ringborg, J. Hansson	20
14	Novel O⁶-methylguanine-DNA methyltransferase SNPs: A frequency comparison of patients with familial melanoma and healthy individuals in Sweden 2002 ·Human Mutation ·Suzanne Egyházi, Shulan Ma, (unknown), Johan Hansson, Anton Platz, Ulrik Ringborg	49
15	Immunohistochemical examination of the expression of O6-methylguanine-DNA methyltransferase in human melanoma metastases 1997 ·European Journal of Cancer ·Suzanne Egyházi, (unknown), Johan Hansson, Ulrik Ringborg	18
16	Role of O6-methylguanine-DNA methyltransferase, glutathione transferase M3-3 and glutathione in resistance to carmustine in a human non-small cell lung cancer cell line 1997 ·European Journal of Cancer ·Suzanne Egyházi, M Edgren, Johan Hansson, (unknown), Bengt Mannervik, Ulrik Ringborg	7
17	Increased Cisplatin Sensitivity of Human Fibroblasts from a Subject with Inherent Glutathione Deficiency 1996 ·Acta Oncologica ·Johan Hansson, Margareta Edgren, Suzanne Egyházi, (unknown), Bengt Mannervik, Ulrik Ringborg	11
18	Analysis of O6-methylguanine-DNA methyltransferase mRNA in fine needle biopsies from human melanoma metastases by reverse transcription and polymerase chain reaction 1996 ·European Journal of Cancer ·Johan Hansson, (unknown), Suzanne Egyházi, Edneia Tani, Anton Platz	9
19	O6-methylguanine-DNA methyltransferase activities in biopsies of human melanoma tumours 1995 ·British Journal of Cancer ·Suzanne Egyházi, Johan Hansson, Ulrik Ringborg	18
20	Carmustine-induced toxicity, DNA crosslinking and 06-methylguanine-DNA methyltransferase activity in two human lung cancer cell lines 1991 ·European Journal of Cancer and Clinical Oncology ·Suzanne Egyházi, Jonas Bergh, Johan Hansson, Peter Karran, Ulrik Ringborg	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact